CellProthera, a biotechnological company, has developed a unique therapeutic technique which enables the structural and functional regeneration of severe post-infarctus cardiac lesions. After European and national (FR/GB) authorization was obtained , CellProthera has started its I/IIB clinical trial in Humans.
Location: France, Great East, Mulhouse
Employees: 11-50
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | Alsace Bus... | alsacebusi... |